# US 2024/0002940 A1 · Methods for the accurate detection of mutations in single molecules of dna

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002940 A1
- Document ID: US20240002940A1
- Status: Published application
- Kind: A1
- Application number: 18/252,524
- Filed: 2021-11-24
- Published: 2024-01-04
- Earliest claimed: 2020-11-24
- Assignees: Genome Research Limited (Gb/Gb)
- Applicants: Genome Research Limited (Gb/Gb)
- Inventors: Federico ABASCAL; Stefanie LENSING; Inigo MARTINCORENA; Robert OSBORNE
- Web page: https://patentgrep.com/patent/US20240002940A1

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 1/6848: characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q 2600/16: Primer sets for multiplex assays
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The invention relates to a method of generating a nucleic acid library for sequencing with error rates <1 error per 100 million base pairs and uses thereof. Provided are methods for detecting mutations (including driver mutations) present in single DNA molecules, such as a single DNA molecule from a polyclonal population of cells, and use of the methods in measuring somatic mutation rates, mutational signatures and driver mutations in vivo or in vitro. Also provided are methods of discovering somatic mutations involved in disease and detecting mutations from cells in culture, diagnosing disease and for detecting the presence and/or identity of a suspected mutation in a cell cultured in vitro and/or subjected to a mutagenic process in vitro. Further provided is a method of computational analysis of duplex sequencing data.

## Claims

### Claim 1

A method of generating a nucleic acid library for sequencing, said method comprising the steps of:
(i) fragmenting a nucleic acid composition to generate fragmented nucleic acid molecules with blunt ends;
(ii) introducing dideoxy nucleotides at internal nick sites present in the fragmented nucleic acid molecules with blunt ends and tailing to generate tailed nucleic acid fragments; and
(iii) adding sequencing adaptors to the tailed nucleic acid fragments to generate a nucleic acid library.

### Claim 2 (depends on 1)

The method according to claim 1, wherein fragmenting the nucleic acid composition in step (i) comprises using one or more blunt/non-cohesive end-generating endonucleases.

### Claim 3 (depends on 2)

The method according to claim 2, wherein using a blunt/non-cohesive end-generating endonuclease prevents the need for end-repair of the fragmented nucleic acid molecules.

### Claim 4 (depends on 2)

The method according to claim 2, wherein the blunt/non-cohesive end-generating endonuclease is a blunt/non-cohesive end-generating restriction endonuclease having a 4 base-pair recognition site and/or which is not impaired by overlapping CpG methylation.

### Claim 5 (depends on 4)

The method according to claim 4, wherein the blunt/non-cohesive end-generating restriction endonuclease is selected from an AluI restriction endonuclease or an HpyCH4 restriction endonuclease.

### Claim 6 (depends on 1)

The method according to claim 1, wherein fragmenting the nucleic acid composition in step (i) comprises removing overhangs from the fragmented nucleic acid molecules using one or more exonuclease enzymes to generate fragmented nucleic acid molecules with blunt ends.

### Claim 7 (depends on 6)

The method according to claim 6, wherein fragmenting the nucleic acid composition in step (i) comprises mechanical fragmentation.

### Claim 8

A method of generating a nucleic acid library for sequencing, said method comprising the steps of:
(i a) fragmenting a nucleic acid composition by sonication to generate fragmented nucleic acid molecules;
(i b) removing overhangs from the fragmented nucleic acid molecules using one or more exonuclease enzymes to generate fragmented nucleic acid molecules with blunt ends;
(ii) introducing dideoxy nucleotides at internal nick sites present in the fragmented nucleic acid molecules and tailing to generate tailed nucleic acid fragments; and
(iii) adding sequencing adaptors to the tailed nucleic acid fragments to generate a nucleic acid library.

### Claim 9 (depends on 8)

The method according to claim 8, wherein the one or more exonuclease enzymes is Mung Bean nuclease.

### Claim 10 (depends on 1)

The method according to claim 1, wherein introducing dideoxy nucleotides at internal nick sites in step (ii) prevents extension of the internal nick and results in an unamplifiable nucleic acid strand.

### Claim 11 (depends on 1)

The method according to claim 1, wherein
(i) the dideoxy nucleotides introduced in step (ii) are dideoxy non-A nucleotides, and optionally the tailing of the fragmented nucleic acid molecules in step (ii) comprises A-tailing; or
(ii) the dideoxy nucleotides introduced in step (ii) are dideoxy non-C nucleotides, and optionally the tailing of the fragmented nucleic acid molecules in step (ii) comprises C-tailing; or
(iii) the dideoxy nucleotides introduced in step (ii) are dideoxy non-G nucleotides, and optionally the tailing of the fragmented nucleic acid molecules in step (ii) comprises G-tailing; or
(iv) the dideoxy nucleotides introduced in step (ii) are dideoxy non-T nucleotides, and optionally the tailing of the fragmented nucleic acid molecules in step (ii) comprises T-tailing.

### Claim 12 (depends on 1)

The method according to claim 1, wherein the sequencing adaptors are duplex sequencing adaptors comprising a barcode sequence.

### Claim 13 (depends on 1)

The method according to claim 1, wherein the nucleic acid library is for duplex sequencing.

### Claim 14 (depends on 1)

The method according to claim 1, additionally comprising the step of:
(iv) selectively enriching nucleic acids corresponding to one or more genomic region of interest to generate an enriched nucleic acid library.

### Claim 15 (depends on 14)

The method of claim 14, wherein the one or more genomic region of interest is one or more coding sequences (CDSs) of coding genes.

### Claim 16 (depends on 15)

The method according to claim 15, wherein the method is for generating a nucleic acid library for exome sequencing and selectively enriching nucleic acids corresponding to genomic regions of interest in step (iv) comprises using oligonucleotide probes which bind to the coding sequences (CDSs).

### Claim 17 (depends on 1)

A method for detecting mutations present in single DNA molecules, said method comprising the steps of:
(i) generating a nucleic acid library or an enriched nucleic acid library using the method according to claim 1;
(ii) sequencing the nucleic acid library or the enriched nucleic acid library to generate sequencing data; and
(iii) performing computational analysis of the sequencing data of step (ii) to detect the presence and/or identity of a mutation in single DNA molecules.

### Claim 18 (depends on 17)

The method of claim 17, wherein the computational analysis of step (iii) comprises
(a) aligning to a reference genome;
(b) grouping reads of the sequencing data using a combination of fragmentation breakpoint positions, duplex barcode sequences, sequencing read and strand identity, or identifying and grouping reads of the sequencing data based on the position in the reference genome to which they correspond and/or the nucleic acid fragment from which they derive;
(c) providing a consensus base call quality score; and
(d) filtering false positive base calls at both reference and mutated positions.

### Claim 19 (depends on 1)

A method for detecting a mutation present in a single DNA molecule from a population of cells, comprising performing the method of claim 1.

### Claim 20 (depends on 19)

The method according to claim 19, wherein the population of cells is a polyclonal population of cells.

### Claim 21 (depends on 19)

The method according to claim 19, wherein the population of cells is an aged population of cells or a diseased population of cells.

### Claim 22 (depends on 19)

The method according to claim 19, wherein the mutation present in a single DNA molecule is a driver mutation.

### Claim 23 (depends on 22)

The method according to claim 22, wherein the driver mutation is involved in an ageing process or is a disease driver mutation.

### Claim 24 (depends on 19)

A method of diagnosing disease in a human or animal subject, said method comprising the steps of:
(i) detecting the presence and/or identity of a mutation in a single DNA molecule according to the method of claim 19; and
(ii) using the presence and/or identity of the mutation as an indicator of disease in the human or animal subject.

### Claim 25 (depends on 19)

An in vitro method for detecting the presence and/or identity of a suspected mutation in a cell, said method comprising the steps of:
(i) culturing a cell in vitro and/or subjecting an in vitro cell culture to a mutagenic process, such as by performing gene editing; and
(ii) detecting the presence and/or identity of a mutation in a single DNA molecule in the cell or cell culture, according to the method of claim 19.
